SCHEMBL13686173

SCHEMBL13686173

CC(=O)C(=O)NCS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.60
TDP1 Q9NUW8 3/20 0.60
TP53 P04637 1/20 0.60
MAPT P10636 7/20 0.59
ADAM17 P78536 1/20 0.59
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
KMT2A Q03164 3/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 2/20 0.48
PKM P14618 2/20 0.47
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752911 0.87 ALDH1A1 (0.66) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL7743397 0.87 ALDH1A1 (0.57) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL11325997 0.84 ALDH1A1 (0.71) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL13684867 0.82 ALDH1A1 (0.56) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL21516157 0.77 ALDH1A1 (0.50) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL28619945 0.77 ALDH1A1 (0.57) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL201255 0.77 ALDH1A1 (0.57) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL20353419 0.76 ALDH1A1 (0.47) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL11207452 0.76 ALDH1A1 (1.00) ALDH1A1TDP1TP53MAPTADAM17
SCHEMBL3975244 0.75 ALDH1A1 (0.59) ALDH1A1TDP1TP53MAPTADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 US disclosed